GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MedAssets Inc (NAS:MDAS) » Definitions » Current Ratio

MedAssets (MedAssets) Current Ratio : 0.55 (As of Sep. 2015)


View and export this data going back to . Start your Free Trial

What is MedAssets Current Ratio?

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. MedAssets's current ratio for the quarter that ended in Sep. 2015 was 0.55.

MedAssets has a current ratio of 0.55. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If MedAssets has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.

The historical rank and industry rank for MedAssets's Current Ratio or its related term are showing as below:

MDAS's Current Ratio is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.38
* Ranked among companies with meaningful Current Ratio only.

MedAssets Current Ratio Historical Data

The historical data trend for MedAssets's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedAssets Current Ratio Chart

MedAssets Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
Current Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.65 0.63 0.63 0.55 0.66

MedAssets Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.62 0.66 0.71 0.65 0.55

Competitive Comparison of MedAssets's Current Ratio

For the Health Information Services subindustry, MedAssets's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedAssets's Current Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MedAssets's Current Ratio distribution charts can be found below:

* The bar in red indicates where MedAssets's Current Ratio falls into.



MedAssets Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

MedAssets's Current Ratio for the fiscal year that ended in Dec. 2014 is calculated as

Current Ratio (A: Dec. 2014 )=Total Current Assets (A: Dec. 2014 )/Total Current Liabilities (A: Dec. 2014 )
=176.18/266.509
=0.66

MedAssets's Current Ratio for the quarter that ended in Sep. 2015 is calculated as

Current Ratio (Q: Sep. 2015 )=Total Current Assets (Q: Sep. 2015 )/Total Current Liabilities (Q: Sep. 2015 )
=150.826/275.311
=0.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MedAssets  (NAS:MDAS) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


MedAssets Current Ratio Related Terms

Thank you for viewing the detailed overview of MedAssets's Current Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


MedAssets (MedAssets) Business Description

Traded in Other Exchanges
N/A
Address
MedAssets Inc was incorporated in 1999. It is a financial and performance improvement company providing technology-enabled products and services that, together, help mitigate the increasing financial challenges faced by hospitals, health systems, and other non-acute healthcare providers. Its solutions are designed to reduce the total cost of care delivery, enhance operational efficiency, align clinical delivery of physicians and staff to advance care coordination, and improve revenue performance mainly for hospitals and health systems. The Company's solutions integrate with its clients' existing operations and enterprise software systems, and require minimal upfront costs or capital expenditures for its clients. Its technology-enabled solutions are delivered through company-hosted software, sometimes referred to as software as a service or Web-based applications, supported by implementation, process improvement consulting and outsourced services, as well as enterprise-wide sales and client management support. The Company manages its business through two business segments, Spend and Clinical Resource Management (CM) and Revenue Cycle Management (RCM). Within the SCM segment it provides a comprehensive suite of cost management services, supply chain analytics and data capabilities that help its clients reduce their total cost of care delivery, enhance their operational efficiency and align their clinicians' delivery of care with advance care coordination. Its solutions lower operating costs through compliance to its strategic sourcing of supplies and purchased services at discounted prices, supply chain outsourcing and procurement services capabilities. It also help to improve care processes and reduce care variations through the use of its clinical and process improvement consulting services, workforce optimization solutions and business analytics and intelligence tools. The Company's RCM segment is a provider of revenue cycle management solutions to healthcare providers, mainly hospitals and health systems. It provides SaaS or Web-based software and technology-enabled services designed to improve revenue performance for healthcare organizations through patient access and financial responsibility, clinical documentation, charge capture and revenue integrity, pricing analysis, claims processing and denials management, payor contract management, extended business office revenue recovery, accounts receivable services and outsourcing. As of December 31, 2013, the Company's client base included more than 4,400 acute care hospitals and approximately 122,000 ancillary or non-acute provider locations. The Company competes with Allscripts Corporation, Epic Systems Corporation, McKesson Corporation, Siemens AG; Accenture Ltd., Accretive Health, Inc., Deloitte & Touche LLP, Ernst & Young LLP, Craneware Inc., Emdeon Inc. and among others. The Company is subject to federal and state laws and regulations designed to protect patients, government
Executives
Anthony Jr Colaluca officer: Chief Financial Officer MULTIPLAN CORPORATION, 115 FIFTH AVENUE, NEW YORK NY 10003
Bharat Sundaram officer: President, SCM Segment 100 NORTH POINT CENTER EAST, SUITE 200, ALPHARETTA GA 30022
C A Piccolo director 199 BENSON RD, MIDDLEBURY CT 06749
Carol J Zierhoffer director 100 NORTH POINT CENTER EAST, SUITE 200, ALPHARETTA GA 30022
Kevin M Twomey director 1650 PRUDENTIAL DR, STE 400, JACKSONVILLE FL 32207
Bruce F Wesson director 1827 PACIFIC ST BROOKLYN NY 11233
R Halsey Wise director, officer: Chairman and CEO 135 PONTE VEDRA BLVD, PONTE VEDRA BEACH FL 32082
Samuel K Skinner director 233 NORTH MICHIGAN AVENUE, 22ND FLOOR, CHICAGO IL 60601
Loucks Vernon R Jr director 1101 SKOKIE BLVD., SUITE 240, NORTHBROOK IL 60062
Laurence Neil Hunn officer: President, Revenue Cycle Tech 100 NORTH POINT CENTER EAST, SUITE 200, ALPHARETTA GA 30022
Patrick T Ryan director, officer: President, SCM Segment 401 EDGEWATER PLACE, SUITE 500, WAKEFIELD MA 01880
Claudius Llc 10 percent owner C/O GALEN ASSOCIATES 610 FIFTH AVENUE 5TH FLOOR NEW YORK NY 10020
Galen Partners Iii L P 10 percent owner 610 FIFTH AVE 5TH FL NEW YORK NY 10020
Galen Partners International Iii L P 10 percent owner 610 FIFTH AVENUE 5TH FLOOR NEW YORK NY 10020
Galen Employee Fund Iii Lp 10 percent owner 610 FIFTH AVENUE 5TH FLOOR NEW YORK NY 10020

MedAssets (MedAssets) Headlines

From GuruFocus

MEDASSETS, INC. (MDAS) CFO Laurence Neil Hunn sells 3,100 Shares

By GuruFocus Research GuruFocus Editor 06-03-2010

Litespeed Management adds to its stake in MedAssets

By Tiziano Frateschi Tiziano Frateschi 07-07-2015

MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 9,000 Shares

By GuruFocus Research GuruFocus Editor 03-08-2011

MEDASSETS, INC. (MDAS) Chairman, President and CEO John A Bardis sells 26,776 Shares

By GuruFocus Research GuruFocus Editor 03-01-2010

MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 15,000 Shares

By GuruFocus Research GuruFocus Editor 11-09-2010

MEDASSETS, INC. (MDAS) Chairman, President and CEO John A Bardis sells 10,345 Shares

By GuruFocus Research GuruFocus Editor 03-01-2010

MEDASSETS, INC. (MDAS) Chairman, President and CEO John A Bardis sells 40,000 Shares

By GuruFocus Research GuruFocus Editor 12-01-2010

MEDASSETS, INC. Reports Operating Results (10-K)

By gurufocus 10qk 03-01-2011

MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 15,000 Shares

By GuruFocus Research GuruFocus Editor 02-09-2011

MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 1,400 Shares

By GuruFocus Research GuruFocus Editor 08-06-2010